Insights

Strategic Partnerships Leverage recent Irisbond collaboration to position Oskol 2 as a premier integrated AAC solution for iPad Air users, expanding distribution channels and accelerating market penetration in educational and clinical settings.

Leadership & Guidance Engage the newly appointed Non-Executive Director and strategic advisor Nicholas Opie to access strategic networks, governance credibility, and potential introductions to healthcare funders and research partners.

Product Expansion Capitalize on launches like The Block and EMG-based NeuroStrip applications to cross-sell to AAC users, rehabilitation clinics, sports medicine programs, and neuro-rehabilitation facilities seeking advanced control interfaces.

Market Positioning Highlight NeuroNode as a sixth generation CHI system with broad capabilities (text, TTS, IM, internet, media control) to differentiate from competitors and target mid-sized clinics and school districts with budget ranges aligned to revenue targets.

Industry Engagement Attend and present at key conferences (Closing The Gap, PEAK) to capture lead generation from therapists, educators, and healthcare administrators, while showcasing NeuroStrip and related innovations to secure pilots and early-adopter partnerships.

Control Bionics (ASX:CBL) Tech Stack

Control Bionics (ASX:CBL) uses 8 technology products and services including Facebook Pixel, cdnjs, Cloudflare, and more. Explore Control Bionics (ASX:CBL)'s tech stack below.

  • Facebook Pixel
    Analytics
  • cdnjs
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Infinite Scroll
    Javascript Libraries
  • CloudFlareJS
    Javascript Libraries
  • PHP
    Programming Languages
  • YouTube
    Video Players
  • HTTP/3
    Web & Portal Technology

Media & News

Control Bionics (ASX:CBL)'s Email Address Formats

Control Bionics (ASX:CBL) uses at least 1 format(s):
Control Bionics (ASX:CBL) Email FormatsExamplePercentage
FirstLast@controlbionics.comJohnDoe@controlbionics.com
68%
FLast@controlbionics.comJDoe@controlbionics.com
14%
Last@controlbionics.comDoe@controlbionics.com
11%
FirLast@controlbionics.comJohDoe@controlbionics.com
7%

Frequently Asked Questions

What is Control Bionics (ASX:CBL)'s official website and social media links?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s official website is controlbionics.com and has social profiles on LinkedInCrunchbase.

How much revenue does Control Bionics (ASX:CBL) generate?

Minus sign iconPlus sign icon
As of July 2026, Control Bionics (ASX:CBL)'s annual revenue is estimated to be $1M - $10M.

What is Control Bionics (ASX:CBL)'s NAICS code?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Control Bionics (ASX:CBL) have currently?

Minus sign iconPlus sign icon
As of July 2026, Control Bionics (ASX:CBL) has approximately 41 employees across 2 continents, including OceaniaNorth America. Key team members include Chief Executive Officer: J. S.Chief Financial Officer: S. B.Head Of Sales: A. A.. Explore Control Bionics (ASX:CBL)'s employee directory with LeadIQ.

What industry does Control Bionics (ASX:CBL) belong to?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL) operates in the Medical Equipment Manufacturing industry.

What technology does Control Bionics (ASX:CBL) use?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s tech stack includes Facebook PixelcdnjsCloudflareInfinite ScrollCloudFlareJSPHPYouTubeHTTP/3.

What is Control Bionics (ASX:CBL)'s email format?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s email format typically follows the pattern of FirstLast@controlbionics.com. Find more Control Bionics (ASX:CBL) email formats with LeadIQ.

How much funding has Control Bionics (ASX:CBL) raised to date?

Minus sign iconPlus sign icon
As of July 2026, Control Bionics (ASX:CBL) has raised $7.1M in funding. The last funding round occurred on Jan 31, 2020 for $1.7M.

When was Control Bionics (ASX:CBL) founded?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL) was founded in 2006.
Control Bionics (ASX:CBL) logo

Control Bionics (ASX:CBL)

Medical Equipment ManufacturingVictoria, Australia11-50 Employees

Control Bionics is a medical equipment manufacturer based in Melbourne, Victoria. The company develops dedicated speech generating devices and AAC accessories aimed at giving people with complex communication and physical needs a voice. Its NeuroNode platform is described as a sixth-generation computer-human-interface designed to help users communicate through text, text-to-speech, messaging, emails, and internet access, while also enabling control of entertainment and productivity tasks.
The company serves individuals with significant communication and mobility challenges and operates within the medical equipment sector offering devices and accessories to support communication and daily activities. In May 2026, it announced the appointment of Professor Nicholas Opie as a non-executive director and strategic advisor.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $7.1M

    Control Bionics (ASX:CBL) has raised a total of $7.1M of funding over 4 rounds. Their latest funding round was raised on Jan 31, 2020 in the amount of $1.7Mas a series_b.

  • $1M - $10M

    Control Bionics (ASX:CBL)'s revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $7.1M

    Control Bionics (ASX:CBL) has raised a total of $7.1M of funding over 4 rounds. Their latest funding round was raised on Jan 31, 2020 in the amount of $1.7Mas a series_b.

  • $1M - $10M

    Control Bionics (ASX:CBL)'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.